Table 2

Mean (median) values of demographic, articular, global, self-report questionnaire, and indices of 720 patients from the ESPOIR cohort at baseline and according to whether patients met ACR/EULAR Boolean criteria for remission 6 months after baseline. Data were analyzed according to mean values and t test for normally distributed variables, and median values and Mann-Whitney test for variables that were not normally distributed.

VariablesBaseline, All PatientsBaseline Status of Patients in Remission/Not in Remission 6 Months Later, According to Boolean Remission Criteria
RemissionNot Remissionp
No. patients72093627NA
Age, yrs, mean (± SE)48.2 (12.4)44.9 (12.7)48.7 (12.3)0.007
Sex, % female76.280.675.60.29
Disease duration, mo, median (IQR)4.8 (2.9–7.0)4.0 (2.5–6.1)4.9 (3.0–7.1)0.09
Swollen joint counts (0–28), median (IQR)6 (3–10)4 (2–10)6 (3–10)0.013
Tender joint counts (0–28), median (IQR)6 (3–12)4 (2–8)7 (3–13)< 0.001
Physician global (0-100), mean (± SE)50.8 (22.2)44.0 (22.9)51.8 (21.9)0.0015
ESR, mm/h, median (IQR)22 (12–38)19 (12–35)22 (12–39)0.55
CRP, mg/l, median (IQR)0.9 (0.5–2.5)0.9 (0.3–2)0.9 (0.5–2.5)0.247
HAQ (0–3 scale), median (IQR)0.875 (0.375–1.375)0.625 (0.25–1.25)0.875 (0.375–1.5)0.011
VAS pain (0–100), mean (IQR)46.0 (22.2)36.9 (21.2)47.4 (22.1)< 0.0001
Patient global (0–100), median (IQR)60 (45–80)54.5 (31.5–75.5)65.5 (47–80)0.016
DAS28 (0-10), mean (± SE)5.1 (1.3)4.7 (1.2)5.2 (1.2)0.0005
SDAI (0-86), mean (± SE)29.2 (14.4)24.3 (14.6)29.9 (14.2)0.0005
CDAI (0-76), mean (± SE)26.9 (13.4)22.5 (14.0)27.5 (13.2)0.0007
RAPID3 (0-30), mean (± SE)13.8 (5.7)11.7 (5.8)14.1 (5.6)0.0002
  • IQR: interquartile range; SDAI: Simplified Disease Activity Index; DAS28: Disease Activity Score-28; RAPID3: Routine Assessment of Patient Index Data; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; VAS: visual analog scale; ACR: American College of Rheumatology; EULAR: European League Against Rheumatism; HAQ: Health Assessment Questionnaire; CDAI: Clinical Disease Activity Index; NA: not applicable.